1. Digoxin use and lower risk of 30‐day all‐cause readmission in older patients with heart failure and reduced ejection fraction receiving β‐blockers
- Author
-
Lam, Phillip H, Bhyan, Poonam, Arundel, Cherinne, Dooley, Daniel J, Sheriff, Helen M, Mohammed, Selma F, Fonarow, Gregg C, Morgan, Charity J, Aronow, Wilbert S, Allman, Richard M, Waagstein, Finn, and Ahmed, Ali
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Aging ,Cardiovascular ,Good Health and Well Being ,Adrenergic beta-Antagonists ,Aged ,Alabama ,Cardiotonic Agents ,Digoxin ,Dose-Response Relationship ,Drug ,Drug Therapy ,Combination ,Echocardiography ,Female ,Follow-Up Studies ,Heart Failure ,Heart Ventricles ,Hospital Mortality ,Humans ,Male ,Patient Readmission ,Propensity Score ,Retrospective Studies ,Survival Rate ,Time Factors ,Ventricular Function ,Left ,Hospital Readmission ,-Blockers ,β-Blockers ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundDigoxin use has been associated with a lower risk of 30-day all-cause admission and readmission in patients with heart failure and reduced ejection fraction (HFrEF).HypothesisDigoxin use will be associated with improved outcomes in patients with HFrEF receiving β-blockers.MethodsOf the 3076 hospitalized Medicare beneficiaries with HFrEF (EF
- Published
- 2018